Atlas Trials

Long-term Efficacy and Safety Study of GV-971

Clinical trial NCT05181475 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05181475
Sponsor
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2021-12-07
Primary completion
2025-01-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.